BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 1929159)

  • 1. [Lumbo-aortic lymphadenectomy in ovarian cancers].
    Bonnier P; Piana L
    Ann Chir; 1991; 45(6):450-3; discussion 454-5. PubMed ID: 1929159
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Does systematic lymphadenectomy have a benefit on survival of suboptimally debulked patients with stage III ovarian carcinoma? A DEGOG* Study.
    Saygili U; Guclu S; Uslu T; Erten O; Ture S; Demir N
    J Surg Oncol; 2002 Nov; 81(3):132-7. PubMed ID: 12407725
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Indispensability of pelvic and paraaortic lymphadenectomy in endometrial cancers.
    Yokoyama Y; Maruyama H; Sato S; Saito Y
    Gynecol Oncol; 1997 Mar; 64(3):411-7. PubMed ID: 9062142
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Value of lumbo-aortic curettage in stage I and IIA tubal cancers].
    Rodier JF; Gadonneix P; Dauplat J; Issert B; Giraud B; Fonck Y; Peffault De Latour M
    J Chir (Paris); 1986 Nov; 123(11):663-6. PubMed ID: 3611222
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The place of lumo-aortic and pelvic lymph node dissection in the treatment of ovarian cancer].
    Salet-Lizée D; Alsary S
    J Chir (Paris); 2008 Dec; 145 Spec no. 4():12S45-12S49. PubMed ID: 19194358
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Update on lymphadenectomy in early and advanced ovarian cancer.
    Angioli R; Plotti F; Palaia I; Calcagno M; Montera R; Cafà EV; Sereni MI; Panici PB
    Curr Opin Obstet Gynecol; 2008 Feb; 20(1):34-9. PubMed ID: 18197003
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Ovarian tumors of low malignant potential: an intra- and retroperitoneal disease?].
    Maassen V
    Geburtshilfe Frauenheilkd; 1993 Mar; 53(3):163-8. PubMed ID: 8385641
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of lymphadenectomy in the management of grossly apparent advanced stage epithelial ovarian cancer.
    Aletti GD; Dowdy S; Podratz KC; Cliby WA
    Am J Obstet Gynecol; 2006 Dec; 195(6):1862-8. PubMed ID: 17132488
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lymph node metastasis in stage I epithelial ovarian cancer.
    Suzuki M; Ohwada M; Yamada T; Kohno T; Sekiguchi I; Sato I
    Gynecol Oncol; 2000 Nov; 79(2):305-8. PubMed ID: 11063662
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lymph-vascular space invasion and number of positive para-aortic node groups predict survival in node-positive patients with endometrial cancer.
    Watari H; Todo Y; Takeda M; Ebina Y; Yamamoto R; Sakuragi N
    Gynecol Oncol; 2005 Mar; 96(3):651-7. PubMed ID: 15721407
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Surgery in early-stage ovarian cancer: Article drafted from the French Guidelines in oncology entitled "Initial management of patients with epithelial ovarian cancer" developed by FRANCOGYN, CNGOF, SFOG, GINECO-ARCAGY under the aegis of CNGOF and endorsed by INCa].
    Bolze PA; Collinet P; Golfier F; Bourgin C
    Gynecol Obstet Fertil Senol; 2019 Feb; 47(2):168-179. PubMed ID: 30686727
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic significance of lymph node metastasis and clear cell histology in ovarian carcinoma limited to the pelvis (pT1M0 and pT2M0).
    Sakuragi N; Yamada H; Oikawa M; Okuyama K; Fujino T; Sagawa T; Fujimoto S
    Gynecol Oncol; 2000 Nov; 79(2):251-5. PubMed ID: 11063653
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systematic aortic and pelvic lymphadenectomy versus resection of bulky nodes only in optimally debulked advanced ovarian cancer: a randomized clinical trial.
    Panici PB; Maggioni A; Hacker N; Landoni F; Ackermann S; Campagnutta E; Tamussino K; Winter R; Pellegrino A; Greggi S; Angioli R; Manci N; Scambia G; Dell'Anna T; Fossati R; Floriani I; Rossi RS; Grassi R; Favalli G; Raspagliesi F; Giannarelli D; Martella L; Mangioni C
    J Natl Cancer Inst; 2005 Apr; 97(8):560-6. PubMed ID: 15840878
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Lymphadenectomy in the treatment of malignant ovarian germ cell tumor].
    Jin Y; Pan LY; Huang HF; Shen K; Wu M; Yang JX; Lang JH
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2005 Dec; 27(6):743-8. PubMed ID: 16447650
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytoreductive surgery in advanced epithelial cancer of the ovary: the impact of aortic and pelvic lymphadenectomy.
    Spirtos NM; Gross GM; Freddo JL; Ballon SC
    Gynecol Oncol; 1995 Mar; 56(3):345-52. PubMed ID: 7705667
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effect of retroperitoneal lymphadenectomy on late therapeutic results in testicular tumors].
    Figurin KM
    Vopr Onkol; 1981; 27(4):70-3. PubMed ID: 7195101
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Repeat retroperitoneal lymph node dissection for metastatic testis cancer.
    Sexton WJ; Wood CG; Kim R; Pisters LL
    J Urol; 2003 Apr; 169(4):1353-6. PubMed ID: 12629359
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Retroperitoneal lymphadenectomy and survival of patients treated for an advanced ovarian cancer: the CARACO trial].
    Classe JM; Cerato E; Boursier C; Dauplat J; Pomel C; Villet R; Cuisenier J; Lorimier G; Rodier JF; Mathevet P; Houvenaeghel G; Leveque J; Lécuru F
    J Gynecol Obstet Biol Reprod (Paris); 2011 May; 40(3):201-4. PubMed ID: 21482037
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pattern of retroperitoneal dissemination of primary peritoneum cancer: basis for rational use of lymphadenectomy.
    Aletti GD; Powless C; Bakkum-Gamez J; Wilson TO; Podratz KC; Cliby WA
    Gynecol Oncol; 2009 Jul; 114(1):32-6. PubMed ID: 19361840
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Lymphadenectomy for uterine cancer].
    Gouy S; Uzan C; Zafrani Y; Lhommé C; Pautier P; Duvillard P; Haie-Meder C; Morice P
    J Chir (Paris); 2008 Dec; 145 Spec no. 4():12S51-12S55. PubMed ID: 19194359
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.